Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
All news
(page 12)
29 April 2026
Genentech to present ophthalmology data at ARVO 2026
ARVO presentations: real-world Vabysmo data show retinal drying in wet AMD/DME; Susvimo demonstrates sustained delivery and reduced treatment burden; vamikibart shows early efficacy; >45 abstracts
29 April 2026
SABIC Q1 2026 results
Q1: adjusted EBITDA +25% to SAR4.15bn; revenue -6% to SAR26.15bn; adjusted net income SAR816m; realized $220m recurring EBITDA savings; divestments announced; urea capacity could rise 54%
29 April 2026
Novo Nordisk: Denecimig (Mim8) reduces annualised bleeding rate in haemophilia A regardless of inhibitor status
Denecimig (Mim8) cut annualised bleeding rates in haemophilia A (with/without inhibitors) in Phase 3 FRONTIER2 for once-monthly/weekly dosing; well tolerated, no thromboembolic events
29 April 2026
Evonik opens PEEK magnet‑wire lab in China
China lab develops PEEK rectangular magnet-wire for NEV motors: extrusion/coating, dimensional checks and reliability tests (BDV, PDIV, corona, oil-aging) to accelerate product development.
29 April 2026
GSK Q1 2026 — Specialty Medicines Drive Growth
Q1 sales £7.6bn (+5% CER); Specialty Medicines £3.2bn (+14%). Core operating profit +10%, Core EPS +9%. Strong cash generation; 17p Q1 dividend. 2026 guidance and >£40bn 2031 target reaffirmed.
29 April 2026
MAIRE Q1 2026: Revenues & EBITDA up; 2026 guidance confirmed
Q1: Net income €76.7m (+19.9%); adjusted net cash €396.1m; order intake €4.78bn; backlog €15.73bn; Nextchem revenue +46%; record dividend €0.585/share
News type
Project Updates and Milestones
New Projects and Expansions
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
29 April 2026
INEOS Acetyls and Sandpiper partner on 1.1 MTPA low‑carbon methanol plant in Texas City
FEED starts Q2 2026; FID targeted 2027; first production 2030. ~$1.7B capex. Up to 300,000 t/y to Acetic Acid. ~1,500 construction jobs, 25 permanent. CCS targets 97% capture.
29 April 2026
Exolum to develop Avonmouth CO2 storage hub with Severnside Carbon
New Avonmouth CO2 storage and shipping terminal will open by 2031, handling up to 6Mt/yr via rail and ship to serve southwest England, Midlands and South Wales and enable CCUS access.
29 April 2026
UPM approves Plywood demerger to create listed WISA Group
Board approved plan to spin off a business into a new listed company; EGM approval pending; 1:1 share distribution; target completion Oct 31, 2026; listing expected early Nov 2026.
29 April 2026
ROSI raises €20m+ to scale PV recycling in Europe
€20M+ plus EU grants to fund industrial expansion: 10,000 t/yr solar-panel recycling plant in Spain, scalable automated line, new production director appointed, recycling partnership renewed
29 April 2026
AkzoNobel adds Iris CMX drone for precise aircraft coating inspections
Aerofleet adds a contact-sensor drone to pair with its visual-scan drone, capturing thickness, color and gloss. Dual-drone inspections take ~30 min, improving repaint timing and cutting costs.
29 April 2026
BASF Coatings switches European production to renewable electricity
Completed Europe-wide switch to renewable power, complementing low-CO2 supply in France. Measure cuts Scope-2 emissions, supports 40% per-ton CO2 reduction by 2030 and improves product footprints.
29 April 2026
LANXESS and Fuelcare partner on European fuel biocide distribution
EU-approved fuel biocides (Kathon FP 1.5, Preventol D2/FuelClear M15) to protect stored fuels—prevent microbial growth, sludge and corrosion; includes dosing tech and expanded service hubs.
29 April 2026
BASF’s industrial Cathedral and the ground it stands on
Integrated site captured synergies for decades—cutting costs, funding R&D—but gas-price shock in 2022 exposed systemic risk; response: restructure Ludwigshafen and expand production abroad.
29 April 2026
UPM Q1 2026: Strong start led by decarbonization solutions
Q1 sales €2,505m; comparable EBIT €274m (-5%); operating cash flow €89m; net debt €2,962m. Energy and biofuels strong. H1 comparable EBIT guidance €325–525m.
29 April 2026
FUCHS starts 2026 strongly amid volatile markets
Q1 sales +1% to €934m; record EBIT €125m; EPS €0.68 (+15%). FY EBIT target €450m confirmed; sales guidance above €3.7bn. Raw‑material and supply risks weigh on cash flow.
29 April 2026
Statkraft and Hydro sign 10-year power PPAs for 12.3 TWh
Contracts secure power for primary aluminium production in Norway, allocating deliveries across NO2 and NO3 price areas and supporting long-term industrial competitiveness and low-carbon solutions.
29 April 2026
TotalEnergies completes 50% acquisition of EPH flexible power portfolio in Europe
Creates TTEP: 14 GW flexible gas/biomass + BESS across Italy, UK, Ireland, Netherlands, France; ~30 TWh output in 2025; tolling contracts; 5 GW development pipeline.
29 April 2026
TotalEnergies Q1 2026 Results
Press release (Paris, Apr 29, 2026) announcing financial results; links to full details and investor information.
29 April 2026
Symrise Q1 2026: Organic sales -0.4%, full-year outlook reaffirmed
Strength in Food & Beverage, Pet Food, Fragrance; Taste, Nutrition & Health +1.7%, Scent & Care -3.4%. ONE SYM driving cost savings and reinvestment; APAC & Americas up, EMEA down
29 April 2026
Neste Q1 2026 Interim Report
Strong Q1: comparable EBITDA EUR 861m; cash flow before financing EUR 286m; renewable margin USD 856/t; oil refining margin USD 23.0/bbl; leverage 31.7%; volumes hit by maintenance
29 April 2026
Worley to deliver FEED for Dow Path2Zero cogeneration in Canada
FEED for cogeneration with post-combustion carbon capture; brownfield unit targeted by 2030 to support net-zero Scope 1/2 and expand low-carbon polyethylene output.
28 April 2026
Sinopec RIPP’s Sinoketol wins Gold at Geneva Invention Exhibition
New cyclohexanone route via cyclohexene esterification–hydrogenation: >99.95% single‑pass conversion, >8× equilibrium, −14% activation energy; waste −70%, CO₂ −38%; first commercial 2×200k t/yr unit
28 April 2026
Plastic Ingenuity adopts PureCycle PureFive recycled PP for coffee lids
Coffee lids now use 25-100% recycled polypropylene from a dissolution process; material retains virgin-like performance, has FDA food-contact clearance and GreenCircle certification.
28 April 2026
GSK: FDA grants priority review and Breakthrough Therapy for bepirovirsen
Phase III B-Well trials showed significantly higher functional cure rates and acceptable safety in chronic hepatitis B; drug is an antisense oligonucleotide; PDUFA date 26 Oct 2026
28 April 2026
PPG Q1 2026 results
Q1 net sales $3.93B (+7%), organic +1% on price. Adjusted EPS $1.83 (+6%). Segment margin 16%, EBITDA margin 19%. ~$100M buybacks. Reaffirms FY EPS $7.70–8.10.
28 April 2026
UPM joint venture with Sappi enters EU Phase II merger review
EC opened Phase II on 28 Apr 2026. The proposed graphic-paper JV needs approvals in other jurisdictions; parties are cooperating and say the deal strengthens European supply resilience.
28 April 2026
BASF commissions world-scale menthol and linalool plants in Ludwigshafen and citral plant in Zhanjiang
Commercial production began April 2026; Ludwigshafen expansion leverages Verbund efficiencies, Zhanjiang citral boosts supply reliability and downstream feedstock; ~60 jobs.
28 April 2026
MAIRE's Nextchem awarded NX CONSER C5+ license and process design for TMA plant in China
Licensed process design and technical services for a continuous Trimellitic Anhydride (TMA) plant in China, cuts power, steam and water use; two-phase rollout, optional proprietary equipment.
28 April 2026
Novo Nordisk to present Wegovy and next‑generation obesity data at ECO 2026
Presenting 52 abstracts at ECO: data on semaglutide (injectable and oral), higher‑dose 7.2 mg, CagriSema combo, menopause effects, CV risk, weight‑loss timelines and real‑world outcomes.
← Previous
Next →